Larkspur Bioscience


Month: January 2024

Oncology’s Next Frontier: ADCs, Radiopharma and the Future of Cancer Treatment

Posted on January 10, 2024February 1, 2024 by Catherine Sabatos-Peyton

Fierce JPM Week panel (3:40pm PST) with CEO Catherine Sabatos-Peyton and other industry experts from Merck, Abbvie and more (free registration required)

Posted in PRESENTATION PLAYBACKLeave a Comment on Oncology’s Next Frontier: ADCs, Radiopharma and the Future of Cancer Treatment

Recent Posts

  • Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
  • Oncology’s Next Frontier: ADCs, Radiopharma and the Future of Cancer Treatment
  • Larkspur Biosciences Announces CEO Catherine Sabatos-Peyton to Participate in Upcoming Biotech Events
  • Larkspur Biosciences to Present New Mechanistic Data on the Role of Pin1 in Modulating the Fibroblast – Cancer Axis at SITC 2023
  • Larkspur Biosciences Announces First-in-Class Program Targeting Novel B Cell Checkpoint

Recent Comments

No comments to show.

Archives

  • March 2024
  • January 2024
  • December 2023
  • October 2023
  • June 2023
  • May 2023

Categories

  • PRESENTATION PLAYBACK
  • Press Release

Larkspur Bioscience is proudly powered by WordPress